These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16804339)

  • 1. [Immunology of hepatitis C: clinical significance of T cell response].
    Shin EC
    Korean J Hepatol; 2006 Jun; 12(2):140-53. PubMed ID: 16804339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell response in hepatitis C virus infection.
    Neumann-Haefelin C; Blum HE; Chisari FV; Thimme R
    J Clin Virol; 2005 Feb; 32(2):75-85. PubMed ID: 15653409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
    Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-based therapy for chronic hepatitis C.
    Chang DY; Shin EC
    J Leukoc Biol; 2009 Jul; 86(1):33-9. PubMed ID: 19395471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
    Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
    Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive immune responses in acute and chronic hepatitis C virus infection.
    Bowen DG; Walker CM
    Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C immunology].
    Alvarado Esquivel C; Leroux-Roels G
    Rev Invest Clin; 1999; 51(5):315-22. PubMed ID: 10614142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
    Folgori A; Capone S; Ruggeri L; Meola A; Sporeno E; Ercole BB; Pezzanera M; Tafi R; Arcuri M; Fattori E; Lahm A; Luzzago A; Vitelli A; Colloca S; Cortese R; Nicosia A
    Nat Med; 2006 Feb; 12(2):190-7. PubMed ID: 16462801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic hepatitis C: virologic and immunologic aspects and questions of therapy].
    Pár A
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1465-76. PubMed ID: 9221376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
    Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
    Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of hepatitis C virus infection].
    Montaño-Loza A; Meza-Junco J; Remes-Troche JM
    Rev Invest Clin; 2001; 53(6):561-8. PubMed ID: 11921530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of hepatitis C virus infection and related liver disease.
    Pawlotsky JM
    Trends Microbiol; 2004 Feb; 12(2):96-102. PubMed ID: 15036326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the hepatitis C virus and the immune system.
    Rehermann B
    Semin Liver Dis; 2000; 20(2):127-41. PubMed ID: 10946419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
    Klade CS; Wedemeyer H; Berg T; Hinrichsen H; Cholewinska G; Zeuzem S; Blum H; Buschle M; Jelovcan S; Buerger V; Tauber E; Frisch J; Manns MP
    Gastroenterology; 2008 May; 134(5):1385-95. PubMed ID: 18471515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.
    Salem ML; El-Demellawy M; El-Azm AR
    Cell Immunol; 2010; 262(2):96-104. PubMed ID: 20338549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.